Effect of Parcetamol in Headach

Sponsor
Assiut University
Study ID
NCT06861738
Phase
PHASE3
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Headache

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Paracetamol (acetaminophen) — DRUG
    oral paracetamol 500mg three times per day
  • Paracetamol Placebo — DRUG
    placebo tab three time per day

Study Details

Tension-type headache (TTH) affects about 1 person in 5 worldwide. It is divided into infrequent episodic TTH (fewer than one headache per month), frequent episodic TTH (two to 14 headaches per month), and chronic TTH (15 headache days a month or more). Paracetamol (acetaminophen) is one of a number of analgesics suggested for acute treatment of headaches in frequent episodic TTH.Objectives To assess the efficacy and safety of paracetamol for the acute treatment of frequent episodic TTH in adults.

Key Dates

First listed
Mar 6, 2025
Start date
Mar 1, 2025
Status verified
Jan 2025
Primary completion
Mar 1, 2026
Completion
Apr 1, 2027

Study Design

Enrollment
100 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Group A
    patients will recive paracetamol
  • Placebo Comparator: groupB
    patients will recive placebo

Primary Outcome Measure

pain score VAS score [ Time Frame: 24 hours ]

Central Contacts

Related Studies